illustration of dad with mom holding a baby
page hero image

Here for her health

We envision a better and healthier every day for every woman

page hero image

Why we're here

We believe in a better and healthier every day for every woman. And we understand that women are foundational to a healthier world. As a new company, we will begin by listening to women’s healthcare needs, big and small, enabling us to develop treatments tailored to them — because we know there is so much more we can do for women and their health.

Get to know us

Our areas of focus

We build upon our strong foundation of more than 60 medicines and other products across a range of areas including reproductive health, heart disease, dermatology, allergies and asthma. And we bring these important therapies around the world, with an international footprint that serves people in more than 140 markets.

Women’s health

We know women need more choices when it comes to their healthcare. Through our portfolio of products specifically designed to address her needs, our goal is to create a better and healthier every day, for every woman.

Illustration of woman climbing a mountain

By providing access to biosimilars as an important treatment option, we aim to bring more choices to more patients who need them.

Established medicines

Our portfolio of established medicines has a long history and cover critical areas including cardiovascular, respiratory, dermatology and non-opioid pain management and more.

Rise together Organon values illustration

Together, we work to address the healthcare issues that matter most to her

Our people – a global community of thousands strong – are united in our drive to better support the health of women within our company and around the globe.

Column one image
Investor relations

A healthcare company for her

We invest in innovations to support the distinct healthcare needs of women today and provide value for our shareholders.

Column one image

Stay in the know

Keep up to date on all things Organon by checking out our latest news.